DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Thabut D, Routray C, Lomberk G. , et al.
Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis.
Hepatology 2011;
54 (02) 573-585
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.